Ceribell, Inc.

CBLL Nasdaq SEC CIK 1861107
Follow Ceribell Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $29.3M +29.9% vs same quarter last year
Net income −$21.4M −58.6% vs same quarter last year
EPS, diluted −$0.55 −48.6% vs same quarter last year
Operating cash flow −$13.1M −17.8% vs same quarter last year
Revenue by quarter
$18.5M
$20.5M
$21.2M
$22.6M
$24.8M
$26.5M
$28.1M
$29.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income4 fiscal years
  • Revenue
  • Net income
−$100M−$50M$0$50M$100MFY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$89.1M−$53.4M
FY24$65.4M−$40.5M
FY23$45.2M−$29.5M
FY22--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2587.9%−65.6%−60%
FY2486.7%−60.7%−61.8%
FY2384.4%−66.4%−65.1%
FY22---
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$41.6M
FY24−$36.4M
FY23−$30.1M
FY22-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Ceribell
  • Healthcare median
−100%−75%−50%−25%0%FY22FY23FY24FY25
Show the numbers
YearCeribellHealthcare median
FY25−60%−30.8%
FY24−61.8%−47%
FY23−65.1%−58%
FY22-−80.4%